Type your drug name (like Atorvastatin, Sildenafil, etc)
Cancel
Advertisement
Januvia Coupon - Januvia 100mg tablet
JanuviaSitagliptin
Sitagliptin (Januvia) is an expensive drug used to treat type 2 diabetes. It helps to control blood sugar. This drug is more popular than comparable drugs. A generic version of Januvia may become available in 2022. It is covered by most Medicare and insurance plans, but some pharmacy coupons or cash prices may be lower. The lowest GoodRx price for the most common version of Januvia is around $435.14, 19% off the average retail price of $540.51. Compare gliptins.
Prescription Settings
brand
tablet
100mg
30 tablets
Januvia Coupon - Januvia 100mg tablet
Januvia(brand)
tablet
100mg
30 tablets

Januvia Latest News

Get the latest updates on this drug from the GoodRx medical team

Save on Prescription Medications With Over 680 Copay Cards on GoodRx.com

Tori Marsh
Tori Marsh -

Have you ever gone to the pharmacy only to realize that you’re on the hook for a high copay or your insurance just won’t cover your medication at all. You’re not alone. Luckily, many drug manufacturers offer savings through copay cards, also known as manufacturer coupons. These programs are typically for brand-name drugs, and can lower the price of your medication to as little as $0.

GoodRx currently has information on over 680 active copay cards for hundreds of prescription medications. See More

43 Drugs Going Generic in the Next 5 Years (2018-2022)

Tori Marsh
Tori Marsh -

Brand-only drugs like Restasis, Eliquis and Lyrica can cost well over $500 for a month’s supply, and without cheaper generic alternatives, patients are often forced to either shell out their life savings or give up essential medications. FDA initiatives to expedite the drug review process and prohibit manufacturers from holding market exclusivity for too long will hopefully bring many generics to the market soon. See More

Trulicity vs. Victoza vs. Bydureon — Which is Better for Diabetes?

Dr. Sharon Orrange
Dr. Sharon Orrange -

Trulicity, Victoza, and Bydureon all belong to a newer class of non-insulin diabetes medications known as GLP-1 (glucagon-like peptide-1) receptor agonists that improve blood sugar control and may lead to weight loss. They were each approved by the FDA in the last decade, and increase how much insulin the pancreas makes in response to high glucose levels.

Which drug is the most effective?

Trulicity (dulaglutide), approved in 2014, is the newest out of these three drugs. See More

Here Are the 5 Best Ways To Save on Invokana, the Diabetes Drug

Tori Marsh
Tori Marsh -

Let’s start with the bad news. Invokana, a tablet taken to treat type 2 diabetes, is really expensive. A 30-day supply of Invokana can cost around $550, and we may have to wait another six years to see a generic. But there is good news — there are ways to save.

Here’s all the information you need to make your Invokana prescription affordable.

How popular is Invokana?

Approved in 2013, Invokana is one of the most popular SGLT2 inhibitors, a class of drugs that is used to treat diabetes type 2 by blocking the kidneys from reabsorbing glucose so any excess is excreted from the body. See More

The Top 10 Most Expensive Popular Brand-Name Drugs in the US (and How To Save)

Tori Marsh
Tori Marsh -

Brand drugs are expensive — this we already know, and prices seem to only be increasing. Of the 100 most-prescribed brand-name medications, those for diabetes, rheumatoid arthritis, and Crohn’s disease tend to be the most expensive. All of the drugs on this list are brand-only medications, meaning that there are no affordable generic alternatives available.

Additionally, it can be difficult for people to receive adequate insurance coverage for many of these drugs as they may be placed in more expensive, higher-tier formularies or have some other coverage restrictions. See More

Here’s How to Save on Diabetes Medication Januvia

Tori Marsh
Tori Marsh -

Between the supplies, the physician visits, and the prescription medications, treating diabetes can be expensive. In fact, the average patient spends an average of $7,900 per year to treat their diabetes. Doctors consistently report that the high costs for diabetes medications can result in low levels of adherence, so it is important for patients to find ways to save.   

For many people, Januvia (sitagliptin) is unaffordable. See More

Why Taking Your Medications for These Common “Silent” Diseases is Important

Roni Shye
Roni Shye -

If you’ve ever been afraid to show up at your doctor’s office because you’ve been “bad” then this post is for YOU!  You may think your doctor is “pushing medications on you” especially if you aren’t experiencing any symptoms of the condition they are treating you for. However, their reasoning is not without sound medical and professional judgment. 

One of the many reasons you might receive a lecture about the importance of taking your medications is due to the progressive nature of many diseases if not properly treated. See More

5 Ways to Save More on Your Diabetes Meds

Dr. Sharon Orrange
Dr. Sharon Orrange -

More than 29 million Americans have diabetes. That’s more than 10% of the US—and that number continues to rise. More than 1.7 million adults were diagnosed with diabetes in 2012 alone.

Fortunately, several new medications for diabetes have recently been approved—Toujeo (a new insulin product), Synjardy (a new combination of empagliflozin/metformin) and others. These new drugs provide several benefits such as fewer side effects or foolproof self-dosing with an insulin pen. See More

FDA Issues Warning on Joint Pain with Diabetes Medications

Roni Shye
Roni Shye -

On August 28, 2015, the FDA issued a safety warning for a newer type of type 2 diabetes medication known as DPP-4 inhibitors or gliptins.

There have been reports that these medications can cause severe and possibly disabling joint pain.

Which medications contain gliptins (DPP-4 inhibitors)?

Why was a FDA safety warning issued for gliptin medications?

The FDA issued the warning due to continued reports of severe joint pain associated with the use of gliptin medications. See More

What’s New in Diabetes Treatment?

Dr. Sharon Orrange
Dr. Sharon Orrange -

2013 was a year for many new treatments for type II diabetes. For healthcare workers and patients it’s hard to keep up with the newer medications for the treatment of adult onset diabetes, and treating diabetes is an art and not a “one-size fits all” algorithm. For our folks struggling with type II diabetes the outlook just got brighter because of a class of drugs known as incretin based drugs. Here is the down-low on these medications. See More

Copyright ©2018 GoodRx, Inc.
GoodRx is not sponsored by or affiliated with any of the pharmacies identified in its price comparisons. All trademarks, brands, logos and copyright images are property of their respective owners and rights holders and are used solely to represent the products of these rights holders. This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment.
In all states except Tennessee, GoodRx is considered a marketer of prescription discount cards, and is not required to register as a discount card provider. In Tennessee, GoodRx is registered as a Prescription Drug Discount Plan Operator.
LegitScript SealNABP SealBBB Seal